AGÕæÈ˹ٷ½

STOCK TITAN

[SCHEDULE 13G/A] Intensity Therapeutics, Inc. Common stock SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G/A





Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)






SCHEDULE 13G





SCHEDULE 13G



SAPIENT CAPITAL LLC
Signature:MAXIMILAAN RIJKENBERG
Name/Title:CHIEF COMPLIANCE OFFICER AND CHIEF LEGAL OFFICER
Date:07/09/2025
INTENSITY THERAPEUTICS INC

NASDAQ:INTS

INTS Rankings

INTS Latest News

INTS Latest SEC Filings

INTS Stock Data

13.70M
40.82M
13.25%
4.24%
2.05%
Biotechnology
Biological Products, (no Disgnostic Substances)
United States
SHELTON